Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment.

Autor: Aden D; Department of Pathology, Hamdard Institute of Medical Science and Research, New Delhi, India., Sureka N; Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India., Zaheer S; Department of Radiotherapy, Jawaharlal Nehru Medical College, AMU, Aligarh, India., Chaurasia JK; Department of Pathology and Laboratory Medicine, AIIMS, Bhopal, India., Zaheer S; Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

Publikováno v: Immunology [Immunology] 2025 Jan; Vol. 174 (1), pp. 30-72. Date of Electronic Publication: 2024 Oct 27.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment

Autor: G, Frumento, S, Franchello, G L, Palmisano, M R, Nicotra, P, Giacomini, Y W, Loke, D E, Geraghty, M, Maio, C, Manzo, P G, Natali, G B, Ferrara

Publikováno v: Tissue antigens. 56(1)

HLA-G is an effective ligand of natural killer (NK) inhibitory receptors, HLA-G transcripts have been detected in several human tumors, and cytokines like gamma interferon (IFN) enable HLA-G molecules to be expressed. These findings are particularly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9a994a74597324ddc00aa36da366a420
https://pubmed.ncbi.nlm.nih.gov/10958353

Activation-related differences in HLA class I-bound peptides: presentation of an IL-1 receptor antagonist-derived peptide by activated, but not resting, CD4+ T lymphocytes

Autor: G, Frumento, A, Corradi, G B, Ferrara, A, Rubartelli

Publikováno v: Journal of immunology (Baltimore, Md. : 1950). 159(12)

We have compared by reverse phase HPLC the set of peptides eluted from HLA class I molecules in resting and activated CD4+ Jurkat cells. Two peptides were identified that are presented de novo upon activation. After sequencing, one of these peptides

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::116753c79a566000033651f4285ab0ab
https://pubmed.ncbi.nlm.nih.gov/9550397